227 related articles for article (PubMed ID: 28588554)
1. Female Reproductive Factors and Differentiated Thyroid Cancer.
Moleti M; Sturniolo G; Di Mauro M; Russo M; Vermiglio F
Front Endocrinol (Lausanne); 2017; 8():111. PubMed ID: 28588554
[TBL] [Abstract][Full Text] [Related]
2. Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis.
O'Grady TJ; Rinaldi S; Michels KA; Adami HO; Buring JE; Chen Y; Clendenen TV; D'Aloisio A; DeHart JC; Franceschi S; Freedman ND; Gierach GL; Giles GG; Lacey JV; Lee IM; Liao LM; Linet MS; McCullough ML; Patel AV; Prizment A; Robien K; Sandler DP; Stolzenberg-Solomon R; Weiderpass E; White E; Wolk A; Zheng W; Berrington de Gonzalez A; Kitahara CM
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38110618
[TBL] [Abstract][Full Text] [Related]
3. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
[TBL] [Abstract][Full Text] [Related]
4. The Association of Pregnancy with Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer: A Propensity Score-Matched Retrospective Cohort Study.
Li X; Xiao WC; Mei F; Shan R; Song SB; Sun BK; Bao HL; Chen J; Yuan CH; Liu Z
J Womens Health (Larchmt); 2023 Nov; 32(11):1174-1181. PubMed ID: 37638829
[No Abstract] [Full Text] [Related]
5. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
[TBL] [Abstract][Full Text] [Related]
7. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy.
Vannucchi G; Perrino M; Rossi S; Colombo C; Vicentini L; Dazzi D; Beck-Peccoz P; Fugazzola L
Eur J Endocrinol; 2010 Jan; 162(1):145-51. PubMed ID: 19828692
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of thyroid cancer related to pregnancy: a systematic review.
Alves GV; Santin AP; Furlanetto TW
J Thyroid Res; 2011; 2011():691719. PubMed ID: 21811666
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
Sun R; Yang L; Hu Y; Wang Y; Zhang Q; Zhang Y; Ji Z; Zhao D
Oncol Lett; 2020 Nov; 20(5):240. PubMed ID: 32973954
[TBL] [Abstract][Full Text] [Related]
12. Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression.
Tafani M; De Santis E; Coppola L; Perrone GA; Carnevale I; Russo A; Pucci B; Carpi A; Bizzarri M; Russo MA
Biomed Pharmacother; 2014 Feb; 68(1):1-5. PubMed ID: 24286852
[TBL] [Abstract][Full Text] [Related]
13. Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies.
Caini S; Gibelli B; Palli D; Saieva C; Ruscica M; Gandini S
Cancer Causes Control; 2015 Apr; 26(4):511-8. PubMed ID: 25754110
[TBL] [Abstract][Full Text] [Related]
14. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
15. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
Chow SM; Yau S; Lee SH; Leung WM; Law SC
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
[TBL] [Abstract][Full Text] [Related]
17. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
18. Sex hormones and headache.
Silberstein SD
Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
[TBL] [Abstract][Full Text] [Related]
19. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
Sawka AM; Lakra DC; Lea J; Alshehri B; Tsang RW; Brierley JD; Straus S; Thabane L; Gafni A; Ezzat S; George SR; Goldstein DP
Clin Endocrinol (Oxf); 2008 Sep; 69(3):479-90. PubMed ID: 18284643
[TBL] [Abstract][Full Text] [Related]
20. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
